Correlation Between HCW Biologics and Biofrontera
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Biofrontera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Biofrontera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Biofrontera, you can compare the effects of market volatilities on HCW Biologics and Biofrontera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Biofrontera. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Biofrontera.
Diversification Opportunities for HCW Biologics and Biofrontera
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between HCW and Biofrontera is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Biofrontera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Biofrontera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera has no effect on the direction of HCW Biologics i.e., HCW Biologics and Biofrontera go up and down completely randomly.
Pair Corralation between HCW Biologics and Biofrontera
Given the investment horizon of 90 days HCW Biologics is expected to generate 6.33 times more return on investment than Biofrontera. However, HCW Biologics is 6.33 times more volatile than Biofrontera. It trades about 0.12 of its potential returns per unit of risk. Biofrontera is currently generating about 0.04 per unit of risk. If you would invest 45.00 in HCW Biologics on August 31, 2024 and sell it today you would earn a total of 2.00 from holding HCW Biologics or generate 4.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Biofrontera
Performance |
| Timeline |
| HCW Biologics |
| Biofrontera |
HCW Biologics and Biofrontera Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Biofrontera
The main advantage of trading using opposite HCW Biologics and Biofrontera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Biofrontera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will offset losses from the drop in Biofrontera's long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Biofrontera vs. Shuttle Pharmaceuticals | Biofrontera vs. Akanda Corp | Biofrontera vs. China Pharma Holdings | Biofrontera vs. Sunshine Biopharma Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |